Andalan Sakti Primaindo Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Andalan Sakti Primaindo Tbk trades at Rp410 (market cap 280.36B, 170.8K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Andalan Sakti Primaindo Tbk and Diagnos Laboratorium Utama Tbk. are close in size by market cap, and Andalan Sakti Primaindo Tbk is more actively traded (170.8K versus 41.7K). Which is the better fit depends on your goals.
| ASPI | DGNS | |
|---|---|---|
Market Cap | 280.36B | 316.25B |
Volume | 170.8K | 41.7K |
Lot | 1.71K | 417 |
Turnover | 70.08M | 9.66M |
Average Price | 410.28 | 231.65 |
Value | 70.08M | 9.66M |
Indicative Equilibrium Price | 410 | 230 |
Indicative Equilibrium Volume | 50 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Andalan Sakti Primaindo Tbk. ("the Company") was established based on the Notarial Deed of Saniwati Suganda, S.H., No.81 dated 13 November 2012. Entiry parent is PT Andalan Sakti Inti.
Read more on ASPI →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →